Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.02% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 2.17% |
| 4 | Financials | 2.1% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
CALL
West Pharmaceutical
WST
$24.6B
| $14.5M | ﹤0.01% |
48,200
+1,200
| +3% | +$367K |
|
|
2377
West Pharmaceutical
WST
$24.6B
| $14.4M | ﹤0.01% |
48,126
-232,218
| -83% | -$71.1M |
|
2378
ProShares UltraPro QQQ
TQQQ
$38.5B
| $14.4M | ﹤0.01% |
397,938
+207,140
| +109% | +$7.1M |
|
2379
PUT
Schwab US Dividend Equity ETF
SCHD
$108B
| $14.4M | ﹤0.01% |
511,800
+403,200
| +371% | +$11M |
|
2380
Edgewise Therapeutics
EWTX
$4.8B
| $14.4M | ﹤0.01% |
538,249
-1,810,925
| -77% | -$36M |
|
2381
CALL
iShares MSCI Turkey ETF
TUR
$222M
| $14.3M | ﹤0.01% |
394,200
+1,600
| +0.4% | +$62.9K |
|
2382
CALL
iShares MSCI India ETF
INDA
$6.56B
| $14.3M | ﹤0.01% |
245,000
-488,900
| -67% | -$27.8M |
|
2383
PUT
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.39B
| $14.3M | ﹤0.01% |
3,540
-809
| -19% | -$3.92M |
|
2384
CALL
Shift4
FOUR
$3.58B
| $14.3M | ﹤0.01% |
161,600
+3,200
| +2% | +$243K |
|
2385
CALL
Zimmer Biomet
ZBH
$19.2B
| $14.3M | ﹤0.01% |
132,600
+21,200
| +19% | +$2.31M |
|
2386
HCA Healthcare
HCA
$87.6B
| $14.3M | ﹤0.01% |
35,147
-15,490
| -31% | -$5.67M |
|
2387
CALL
Academy Sports + Outdoors
ASO
$2.98B
| $14.3M | ﹤0.01% |
244,600
-115,300
| -32% | -$6.29M |
|
|
TEM
2388
CALL
Tempus AI
TEM
$9.4B
| $14.3M | ﹤0.01% |
252,000
+146,100
| +138% | +$6.83M |
|
2389
Summit Therapeutics
SMMT
$10.6B
| $14.3M | ﹤0.01% |
+650,833
| New | +$9.1M |
|
2390
CALL
Eagle Materials
EXP
$6.4B
| $14.2M | ﹤0.01% |
49,500
-8,900
| -15% | -$2.23M |
|
2391
CALL
Green Plains
GPRE
$1.09B
| $14.2M | ﹤0.01% |
1,051,000
+779,100
| +287% | +$11.4M |
|
2392
Enterprise Products Partners
EPD
$84B
| $14.2M | ﹤0.01% |
488,770
+199,560
| +69% | +$5.83M |
|
2393
AMC Entertainment Holdings
AMC
$2.23B
| $14.2M | ﹤0.01% |
3,126,055
+839,414
| +37% | +$4.18M |
|
2394
PUT
Insulet
PODD
$9.94B
| $14.2M | ﹤0.01% |
61,100
-38,300
| -39% | -$7.86M |
|
|
P
2395
PUT
Everpure Inc
P
$39.3B
| $14.2M | ﹤0.01% |
282,900
+17,800
| +7% | +$1.01M |
|
2396
Energizer
ENR
$1.56B
| $14.2M | ﹤0.01% |
447,372
+395,940
| +770% | +$11.9M |
|
2397
Cellebrite
CLBT
$2.79B
| $14.2M | ﹤0.01% |
843,653
+319,674
| +61% | +$4.74M |
|
2398
PUT
BCE
BCE
$21.9B
| $14.2M | ﹤0.01% |
407,800
-186,900
| -31% | -$6.38M |
|
2399
CALL
iShares S&P 500 Growth ETF
IVW
$77.6B
| $14.2M | ﹤0.01% |
148,200
+142,500
| +2,500% | +$13.2M |
|
2400
Nkarta
NKTX
$167M
| $14.2M | ﹤0.01% |
3,139,235
+13,801
| +0.4% | +$78.4K |
|
Similar funds
Ken Griffin's Q3 2024 Portfolio in Review
As of Q3 2024, Ken Griffin held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Griffin's Q3 2024 filing shows 1,614 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Ken Griffin added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Ken Griffin's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Ken Griffin fully exited Domino's in Q3 2024, selling an estimated $186M.
- Ken Griffin's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Ken Griffin opened 1,614 new positions and closed 1,610 in Q3 2024.
- Ken Griffin's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.